{
  "trial_id": "NCT01596504",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes mellitus, baseline HbA1c, baseline fasting plasma glucose, body mass index (BMI), waist circumference, insulin glargine dose, use of metformin, use of dipeptidyl peptidase 4 (DPP-4) inhibitor, use of sulfonylurea, baseline 24-hour heart rate, baseline blood pressure, baseline body weight.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "HbA1c at Screening (Day -7)",
          "baseline HbA1c"
        ],
        [
          "Metformin Use at Screening",
          "use of metformin"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race",
        "Weight"
      ],
      "remaining_candidate_features": [
        "duration of type 2 diabetes mellitus",
        "baseline fasting plasma glucose",
        "waist circumference",
        "insulin glargine dose",
        "use of dipeptidyl peptidase 4 (DPP-4) inhibitor",
        "use of sulfonylurea",
        "baseline 24-hour heart rate",
        "baseline blood pressure",
        "baseline body weight"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Fasting Plasma Glucose, Insulin Glargine Dose, Use of Metformin, Use of DPP-4 Inhibitor, Use of Sulfonylurea,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race",
          "Race/Ethnicity"
        ],
        [
          "Metformin Use at Screening",
          "Use of Metformin"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "HbA1c at Screening (Day -7)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Duration of Diabetes",
        "Fasting Plasma Glucose",
        "Insulin Glargine Dose",
        "Use of DPP-4 Inhibitor",
        "Use of Sulfonylurea"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Insulin Glargine Dose, Duration of Diabetes, History of Hypertension, History of Hyperlipidemia, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "HbA1c at Screening (Day -7)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Metformin Use at Screening",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Insulin Glargine Dose",
        "Duration of Diabetes",
        "History of Hypertension",
        "History of Hyperlipidemia",
        "History of Cardiovascular Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, glycosylated hemoglobin (HbA1c), fasting plasma glucose, insulin glargine dose, metformin use, dipeptidyl peptidase 4 (DPP-4) inhibitor use, sulfonylurea use, body weight, waist circumference.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race",
          "race"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "HbA1c at Screening (Day -7)",
          "glycosylated hemoglobin (HbA1c)"
        ],
        [
          "Metformin Use at Screening",
          "metformin use"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Weight"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "duration of type 2 diabetes",
        "fasting plasma glucose",
        "insulin glargine dose",
        "dipeptidyl peptidase 4 (DPP-4) inhibitor use",
        "sulfonylurea use",
        "body weight",
        "waist circumference"
      ]
    }
  }
}